MedTrace Logo

A Clinical Study of Chinese Domestic Surgical Robot

NCT04122261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2021-10-25

No results posted yet for this study

Summary

This is a prospective, multi-center, randomized, single-blind, parallel-controlled clinical trial to evaluate the safety and efficacy of the Chinese domestic endoscopic instrument control system in clinical treatment.

Conditions

  • Gallstone
  • Cholecystitis

Interventions

DEVICE

the MicroHand S endoscopic instrument control system

Using the MicroHand S endoscopic instrument control system to treat gallstone or cholecystitis in minimal invasive surgery.

DEVICE

the da Vinci endoscopic instrument control system

Using the da Vinci endoscopic instrument control system to treat gallstone or cholecystitis in minimal invasive surgery.

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER

  • The Third Xiangya Hospital of Central South University

    lead OTHER

Principal Investigators

  • Shaihong Zhu, M.D. · The Third Xiangya Hospital of Central South University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-13
Primary Completion
2020-10-01
Completion
2021-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04122261 on ClinicalTrials.gov